APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Pain Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chronic Pain Treatment Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchChronic Pain Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Pain Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chronic Pain Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Pain Treatment Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Pain Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Chronic Pain Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chronic Pain Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chronic Pain Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chronic Pain Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chronic Pain Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Chronic Pain Treatment include Sanofi, Johnson & Johnson, Novartis AG, Medtronic, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Boston Scientific Corporation and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chronic Pain Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chronic Pain Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Chronic Pain Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Pain Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chronic Pain Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chronic Pain Treatment revenue, projected growth trends, production technology, application and end-user industry.

Chronic Pain Treatment Segment by Company

Sanofi

Johnson & Johnson

Novartis AG

Medtronic

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Boston Scientific Corporation

Bristol-Myers Squibb

AstraZeneca PLC

Becton, Dickinson and Company

Abbott Laboratories

Chronic Pain Treatment Segment by Type

Drugs

Devices

Chronic Pain Treatment Segment by Application

Research Centers

Nursing Homes

Hospitals

Clinics

Chronic Pain Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Pain Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Pain Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Pain Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Chronic Pain Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Chronic Pain Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Pain Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drugs Major Player Table 3. Devices Major Player Table 4. Global Chronic Pain Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Research Centers Major Player Table 6. Nursing Homes Major Player Table 7. Hospitals Major Player Table 8. Clinics Major Player Table 9. Chronic Pain Treatment Industry Trends Table 10. Chronic Pain Treatment Industry Drivers Table 11. Chronic Pain Treatment Industry Opportunities and Challenges Table 12. Chronic Pain Treatment Industry Restraints Table 13. Global Chronic Pain Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Chronic Pain Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Chronic Pain Treatment Market Share by Region (2021-2026) Table 16. Global Chronic Pain Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Chronic Pain Treatment Market Share by Region (2027-2032) Table 18. Global Chronic Pain Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Chronic Pain Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Chronic Pain Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Chronic Pain Treatment Key Players Headquarters & Area Served Table 22. Global Chronic Pain Treatment Players, Product Type & Application Table 23. Global Chronic Pain Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Chronic Pain Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Chronic Pain Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Chronic Pain Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Chronic Pain Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Chronic Pain Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Chronic Pain Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Chronic Pain Treatment Revenue Market Share by Application (2027-2032) Table 36. Sanofi Company Information Table 37. Sanofi Business Overview Table 38. Sanofi Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sanofi Chronic Pain Treatment Product Portfolio Table 40. Sanofi Recent Development Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Johnson & Johnson Chronic Pain Treatment Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. Novartis AG Company Information Table 47. Novartis AG Business Overview Table 48. Novartis AG Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Novartis AG Chronic Pain Treatment Product Portfolio Table 50. Novartis AG Recent Development Table 51. Medtronic Company Information Table 52. Medtronic Business Overview Table 53. Medtronic Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Medtronic Chronic Pain Treatment Product Portfolio Table 55. Medtronic Recent Development Table 56. Eli Lilly and Company Company Information Table 57. Eli Lilly and Company Business Overview Table 58. Eli Lilly and Company Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eli Lilly and Company Chronic Pain Treatment Product Portfolio Table 60. Eli Lilly and Company Recent Development Table 61. Pfizer Company Information Table 62. Pfizer Business Overview Table 63. Pfizer Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Pfizer Chronic Pain Treatment Product Portfolio Table 65. Pfizer Recent Development Table 66. GlaxoSmithKline Company Information Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GlaxoSmithKline Chronic Pain Treatment Product Portfolio Table 70. GlaxoSmithKline Recent Development Table 71. Boston Scientific Corporation Company Information Table 72. Boston Scientific Corporation Business Overview Table 73. Boston Scientific Corporation Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Boston Scientific Corporation Chronic Pain Treatment Product Portfolio Table 75. Boston Scientific Corporation Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bristol-Myers Squibb Chronic Pain Treatment Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. AstraZeneca PLC Company Information Table 82. AstraZeneca PLC Business Overview Table 83. AstraZeneca PLC Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AstraZeneca PLC Chronic Pain Treatment Product Portfolio Table 85. AstraZeneca PLC Recent Development Table 86. Becton, Dickinson and Company Company Information Table 87. Becton, Dickinson and Company Business Overview Table 88. Becton, Dickinson and Company Chronic Pain Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Becton, Dickinson and Company Chronic Pain Treatment Product Portfolio Table 90. Becton, Dickinson and Company Recent Development Table 91. Abbott Laboratories Company Information Table 92. Abbott Laboratories Business Overview Table 93. Abbott Laboratories Chronic Pain Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Abbott Laboratories Chronic Pain Treatment Product Portfolio Table 95. Abbott Laboratories Recent Development Table 96. North America Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Chronic Pain Treatment Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Chronic Pain Treatment Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Chronic Pain Treatment Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Chronic Pain Treatment Revenue by Country (US$ Million) & (2027-2032) Table 110. China Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 111. China Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 112. China Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 113. China Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Chronic Pain Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Chronic Pain Treatment Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Chronic Pain Treatment Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Chronic Pain Treatment Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Chronic Pain Treatment Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Chronic Pain Treatment Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Chronic Pain Treatment Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Chronic Pain Treatment Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Chronic Pain Treatment Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Chronic Pain Treatment Image Figure 2. Global Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Pain Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drugs Image Figure 5. Devices Image Figure 6. Global Chronic Pain Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chronic Pain Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Research Centers Image Figure 9. Nursing Homes Image Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Global Chronic Pain Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Chronic Pain Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Chronic Pain Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Chronic Pain Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Chronic Pain Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Chronic Pain Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Chronic Pain Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Chronic Pain Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chronic Pain Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Chronic Pain Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Chronic Pain Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Chronic Pain Treatment Revenue Share by Type (2021-2032) Figure 25. North America Chronic Pain Treatment Revenue Share by Application (2021-2032) Figure 26. North America Chronic Pain Treatment Revenue Share by Country (2021-2032) Figure 27. United States Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Chronic Pain Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Chronic Pain Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Chronic Pain Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Chronic Pain Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Chronic Pain Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Chronic Pain Treatment Revenue Share by Type (2021-2032) Figure 44. China Chronic Pain Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Chronic Pain Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Chronic Pain Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Chronic Pain Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Chronic Pain Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Chronic Pain Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Chronic Pain Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Chronic Pain Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Chronic Pain Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Chronic Pain Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Devices
Applications
  • Research Centers
  • Nursing Homes
  • Hospitals
  • Clinics
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis AG
  • Medtronic
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Boston Scientific Corporation
  • Bristol-Myers Squibb
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chronic Pain Treatment Market by Type
  3. 1.2.1 Global Chronic Pain Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs
  5. 1.2.3 Devices
  6. 1.3 Chronic Pain Treatment Market by Application
  7. 1.3.1 Global Chronic Pain Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Research Centers
  9. 1.3.3 Nursing Homes
  10. 1.3.4 Hospitals
  11. 1.3.5 Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Chronic Pain Treatment Market Dynamics
  1. 2.1 Chronic Pain Treatment Industry Trends
  2. 2.2 Chronic Pain Treatment Industry Drivers
  3. 2.3 Chronic Pain Treatment Industry Opportunities and Challenges
  4. 2.4 Chronic Pain Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Chronic Pain Treatment Market Perspective (2021-2032)
  2. 3.2 Global Chronic Pain Treatment Growth Trends by Region
  3. 3.2.1 Global Chronic Pain Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chronic Pain Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Chronic Pain Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Chronic Pain Treatment Revenue by Players
  2. 4.1.1 Global Chronic Pain Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Chronic Pain Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Chronic Pain Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chronic Pain Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Chronic Pain Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Chronic Pain Treatment Players, Product Type & Application
  8. 4.5 Global Chronic Pain Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Chronic Pain Treatment Market CR5 and HHI
  11. 4.6.3 2025 Chronic Pain Treatment Tier 1, Tier 2, and Tier 3
5 Chronic Pain Treatment Market Size by Type
  1. 5.1 Global Chronic Pain Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Chronic Pain Treatment Revenue Market Share by Type (2021-2032)
6 Chronic Pain Treatment Market Size by Application
  1. 6.1 Global Chronic Pain Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Chronic Pain Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Chronic Pain Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Chronic Pain Treatment Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Chronic Pain Treatment Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis AG
  14. 7.3.1 Novartis AG Company Information
  15. 7.3.2 Novartis AG Business Overview
  16. 7.3.3 Novartis AG Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Novartis AG Chronic Pain Treatment Product Portfolio
  18. 7.3.5 Novartis AG Recent Developments
  19. 7.4 Medtronic
  20. 7.4.1 Medtronic Company Information
  21. 7.4.2 Medtronic Business Overview
  22. 7.4.3 Medtronic Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Medtronic Chronic Pain Treatment Product Portfolio
  24. 7.4.5 Medtronic Recent Developments
  25. 7.5 Eli Lilly and Company
  26. 7.5.1 Eli Lilly and Company Company Information
  27. 7.5.2 Eli Lilly and Company Business Overview
  28. 7.5.3 Eli Lilly and Company Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly and Company Chronic Pain Treatment Product Portfolio
  30. 7.5.5 Eli Lilly and Company Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Chronic Pain Treatment Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Chronic Pain Treatment Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Boston Scientific Corporation
  44. 7.8.1 Boston Scientific Corporation Company Information
  45. 7.8.2 Boston Scientific Corporation Business Overview
  46. 7.8.3 Boston Scientific Corporation Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boston Scientific Corporation Chronic Pain Treatment Product Portfolio
  48. 7.8.5 Boston Scientific Corporation Recent Developments
  49. 7.9 Bristol-Myers Squibb
  50. 7.9.1 Bristol-Myers Squibb Company Information
  51. 7.9.2 Bristol-Myers Squibb Business Overview
  52. 7.9.3 Bristol-Myers Squibb Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bristol-Myers Squibb Chronic Pain Treatment Product Portfolio
  54. 7.9.5 Bristol-Myers Squibb Recent Developments
  55. 7.10 AstraZeneca PLC
  56. 7.10.1 AstraZeneca PLC Company Information
  57. 7.10.2 AstraZeneca PLC Business Overview
  58. 7.10.3 AstraZeneca PLC Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AstraZeneca PLC Chronic Pain Treatment Product Portfolio
  60. 7.10.5 AstraZeneca PLC Recent Developments
  61. 7.11 Becton, Dickinson and Company
  62. 7.11.1 Becton, Dickinson and Company Company Information
  63. 7.11.2 Becton, Dickinson and Company Business Overview
  64. 7.11.3 Becton, Dickinson and Company Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Becton, Dickinson and Company Chronic Pain Treatment Product Portfolio
  66. 7.11.5 Becton, Dickinson and Company Recent Developments
  67. 7.12 Abbott Laboratories
  68. 7.12.1 Abbott Laboratories Company Information
  69. 7.12.2 Abbott Laboratories Business Overview
  70. 7.12.3 Abbott Laboratories Chronic Pain Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Abbott Laboratories Chronic Pain Treatment Product Portfolio
  72. 7.12.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Chronic Pain Treatment Revenue (2021-2032)
  2. 8.2 North America Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Chronic Pain Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Chronic Pain Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Chronic Pain Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Chronic Pain Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Chronic Pain Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Chronic Pain Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Chronic Pain Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Chronic Pain Treatment Revenue by Country
  11. 8.6.1 North America Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Chronic Pain Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Chronic Pain Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Chronic Pain Treatment Revenue (2021-2032)
  2. 9.2 Europe Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Chronic Pain Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Chronic Pain Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Chronic Pain Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Chronic Pain Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Chronic Pain Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Chronic Pain Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Chronic Pain Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Chronic Pain Treatment Revenue by Country
  11. 9.6.1 Europe Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Chronic Pain Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Chronic Pain Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Chronic Pain Treatment Revenue (2021-2032)
  2. 10.2 China Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Chronic Pain Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Chronic Pain Treatment Revenue by Type (2027-2032)
  5. 10.3 China Chronic Pain Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Chronic Pain Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Chronic Pain Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Chronic Pain Treatment Revenue by Application (2027-2032)
  9. 10.5 China Chronic Pain Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chronic Pain Treatment Revenue (2021-2032)
  2. 11.2 Asia Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Chronic Pain Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Chronic Pain Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Chronic Pain Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Chronic Pain Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Chronic Pain Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Chronic Pain Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Chronic Pain Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Chronic Pain Treatment Revenue by Country
  11. 11.6.1 Asia Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Chronic Pain Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Chronic Pain Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chronic Pain Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Chronic Pain Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Chronic Pain Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Chronic Pain Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Chronic Pain Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Chronic Pain Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Chronic Pain Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Chronic Pain Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Chronic Pain Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Chronic Pain Treatment Revenue by Country
  11. 12.6.1 SAMEA Chronic Pain Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Chronic Pain Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Chronic Pain Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst